1Parmentier J, Becker MM, Heintz U, et al. Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids [J]. Int J Pharm, 2011, 405 (1-2) : 210-217.
2Di Maio S, Carrier RL. Gastrointestinal contents in fasted state and post-lipid ingestion: in vivo measurements and in vitro models for studying oral drug delivery [J]. J Controlled Release, 2011, 151 (2) : 110-122.
4Bahia AP, Azevedo EG, Ferreira LA, et al. New insights into the mode of action of ultradeformable vesicles using calcein as hydrophilic fluorescent marker [J]. Eur J Pharm Sci, 2010, 39 (1-3) : 90-96.
5Conacher M, Alexander J, Brewer JM. Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes) [J]. Vaccine, 2001, 19 (20-22) : 2965-2974.
6Schubert R, Jaroni H, Schoelmerich J, et al. Studies on the mechanism of bile salt-induced liposomal membrane damage [J]. Digestion, 1983, 28 (3) : 181-190.
7Andrieux K, Forte L, Lesieur S, et al. Solubilisation of dipal mitoylphosphatidylcholine bilayers by sodium taurocholate: a model to study the stability of liposomes in the gastrointestinal tract and their mechanism of interaction with a model bile salt [J]. Eur J Pharm Biopharm, 2009, 71 (2) : 346-355.
